301246.SZStock
Verdicts genuinely change. Free email alert the moment 301246.SZ's does — no target price to set, unlike a price alert.
Near limit Ratio screen, 4 of 4 decided standards passing. MSCI Islamic is within 3 points of its line. Even if it crossed, the majority verdict would stay Compliant. What would change it
Whether this company clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
Trade setup
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
301246.SZ is currently considered halal (Sharia-compliant), per our in-house ratio engine. See the full ratio breakdown and business-activity screen below for the reasoning.
This sits among 436 compliant Healthcare stocks we track. See compliant Healthcare stocks →
🕌 In-house Compliance Research
Computed from published company financials, balance sheet as of 2025-12-31. These ratios come from the issuer's own published statements rather than structured SEC data.
AAOIFI divides by the market cap stored with these figures ($1.0B); this record does not say which day it was fetched, so no estimate for today is made from it.
Business activity: not screened
We have not screened this company's line of business, so these ratios say nothing about whether what it does is permissible.
AAOIFI Pass 3 of 3 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 7.25% | 30.00% | Pass(22.7pp buffer) |
| Interest-bearing investments | 21.85% | 30.00% | Pass(8.2pp buffer) |
| Non-permissible income | 0.34% | 5.00% | Pass(4.7pp buffer) |
Usmani Pass 4 of 4 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 8.72% | 33.00% | Pass(24.3pp buffer) |
| Interest-bearing investments | 25.97% | 33.00% | Pass(7.0pp buffer) |
| Non-liquid assets | 66.74% | at least 20.00% | Pass(46.7pp above the floor) |
| Non-permissible income | 0.34% | 5.00% | Pass(4.7pp buffer) |
MSCI Pass 4 of 4 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 8.62% | 33.33% | Pass(24.7pp buffer) |
| Cash + interest-bearing securities | 25.97% | 33.33% | Pass(7.4pp buffer) |
| Accounts receivable | 33.26% | 33.33% | Pass(0.1pp buffer) |
| Non-permissible income | 0.34% | 5.00% | Pass(4.7pp buffer) |
FTSE Pass 4 of 4 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 8.62% | 33.33% | Pass(24.7pp buffer) |
| Cash + interest-bearing securities | 25.97% | 33.33% | Pass(7.4pp buffer) |
| Accounts receivable | 33.26% | 50.00% | Pass(16.7pp buffer) |
| Non-permissible income | 0.34% | 5.00% | Pass(4.7pp buffer) |
Dow Jones Islamic Market Pass 4 of 4 ratios pass
Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 5.86% | 33.00% | Pass(27.1pp buffer) |
| Cash + interest-bearing securities | 17.66% | 33.00% | Pass(15.3pp buffer) |
| Accounts receivable | 4.96% | 33.00% | Pass(28.0pp buffer) |
| Non-permissible income | 0.34% | 5.00% | Pass(4.7pp buffer) |
S&P Shariah Pass 4 of 4 ratios pass
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 5.87% | 33.00% | Pass(27.1pp buffer) |
| Cash + interest-bearing securities | 17.69% | 49.00% | Pass(31.3pp buffer) |
| Accounts receivable | 4.97% | 49.00% | Pass(44.0pp buffer) |
| Non-permissible income | 0.34% | 5.00% | Pass(4.7pp buffer) |
MSCI M-Series Pass 4 of 4 ratios pass
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 5.87% | 33.33% | Pass(27.5pp buffer) |
| Cash + interest-bearing securities | 17.69% | 33.33% | Pass(15.6pp buffer) |
| Accounts receivable | 22.66% | 49.00% | Pass(26.3pp buffer) |
| Non-permissible income | 0.34% | 5.00% | Pass(4.7pp buffer) |
Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.
How close is it to flipping?
Every current reading against its own line, closest first. A verdict is only as durable as that distance.
The numbers the ratios are built from
Read from 301246.SZ's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.
| Line | Figure | As reported | Read from |
|---|---|---|---|
| RevenueTotal revenue for the period | $277.0M | 2025-12-31 | yahoo:annualTotalRevenue |
| Interest-bearing debtShort and long-term borrowings | $75.9M | 2025-12-31 | yahoo:annualTotalDebt |
| Cash and interest-bearing securitiesCash, equivalents and marketable securities | $228.7M | 2025-12-31 | yahoo:annualCashCashEquivalentsAndShortTermInvestments |
| Total assetsBalance sheet total | $880.6M | 2025-12-31 | yahoo:annualTotalAssets |
| Market capDenominator for AAOIFI | $1.0B | live quote | price x shares |
| 36-month average market capDenominator for S&P Shariah and MSCI M-Series | not measured | — | — |
| 24-month average market capDenominator for Dow Jones Islamic Market | not measured | — | — |
| Non-permissible revenueInterest and excluded income | $936.5K | 2025-12-31 | yahoo:annualInterestIncome |
Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.
What changed, and when
Verdict history for 301246.SZ. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.
- 2026-09-07 No change recorded No verdict change for 301246.SZ has been recorded since tracking began. The scan ledger records that the compliance detectors ran, not which symbols each pass covered.
Tracked since 2026-09-07.
What would change the status
The headline verdict is the majority of the decided ratio standards — 4 pass and 0 fail of 7 — with a business-activity screen and any hold applied on top. Balance sheet as of 2025-12-31.
Within 3 points of the line
- MSCI Islamic receivables ratio: 0.1pp buffer
MSCI Islamic is within 3 points of its line. Even if it crossed, the majority verdict would stay Compliant.
The ratios that move with the share price
AAOIFI's debt ratio (7.3% against a 30% line) would only fail if the market cap fell by 76%, to $253.0M.
AAOIFI's investments ratio is $228.7M cash and interest-bearing investments over a market cap of $1.0B, 21.8% against a 30% line.
It would fail if the market cap fell to $762.2M (-27%).
AAOIFI would then fail, and the majority verdict would move from Compliant to no verdict (3 of 4 decided standards passing).
At the screen's market cap, cash and interest-bearing investments would have to rise by $85.3M to reach the line.
AAOIFI would then fail, and the majority verdict would move from Compliant to Not compliant (0 of 4 decided standards passing, counting every standard that divides the same figure).
Only AAOIFI divides by the market cap itself. The Dow Jones, S&P and MSCI M-Series standards divide by a 24- or 36-month average and the others by total assets, so a day's price move does not reach them. Figures are the screen's own; the live market cap differs from the stored one.
Shariah-compliant alternatives
Compliant companies in Drug Manufacturers - Specialty & Generic listed on the same market, largest first. Each is screened on its own; none carries a documented concern or a hold.
| Company | Market cap | Price, day |
|---|---|---|
| 000538.SZYUNNAN BAIYAO GROUP CO.,LTD. | $13.3B | — |
| 002001.SZZhejiang NHU Company Ltd. | $12.1B | — |
| 000963.SZHuadong Medicine Co., Ltd | $7.1B | — |
| 000999.SZChina Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | $5.8B | — |
| 002294.SZShenzhen Salubris Pharmaceuticals Co., Ltd. | $5.0B | — |
A dash means no fresh quote is cached for that symbol; this list does not fetch one.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 34.80 | NEUTRAL |
| Stochastic %K (14) | 5.42 | BUY |
| CCI (20) | -218.97 | BUY |
| Williams %R (14) | -94.58 | BUY |
| MACD (12,26,9) | -0.01 | SELL |
| ROC (10) | -5.11 | SELL |
| Momentum (10) | -0.79 | SELL |
| EMA (10) | 15.38 | SELL |
| SMA (10) | 15.58 | SELL |
| EMA (20) | 15.72 | SELL |
| SMA (20) | 15.61 | SELL |
| EMA (30) | 16.09 | SELL |
| SMA (30) | 16.00 | SELL |
| EMA (50) | 16.97 | SELL |
| SMA (50) | 16.73 | SELL |
| EMA (100) | 18.86 | SELL |
| SMA (100) | 19.33 | SELL |
| EMA (200) | 20.61 | SELL |
| SMA (200) | 22.14 | SELL |
SMC — Top Down
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
Before you act on this
The questions worth asking about any verdict on this page, answered plainly.
Is this a fatwa?
No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.
Why can the standards disagree?
Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.
How often is this re-screened?
Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.
Do I need to purify dividends?
If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Compare with
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.